Meritage Portfolio Management Organon & Co. Transaction History

Meritage Portfolio Management

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	BUY	$23.31 - $28.61 $2.17 Million - $2.66 Million	93,045 Added 115.56%	173,562 $4.85 Million
Q3 2022 Oct 25, 2022	SELL	$23.4 - $34.25 $1.33 Million - $1.95 Million	-56,941 Reduced 41.42%	80,517 $1.88 Million
Q2 2022 Jul 25, 2022	BUY	$31.66 - $38.9 $4.35 Million - $5.35 Million	137,458 New	137,458 $4.64 Million

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Meritage Portfolio Management, based on Form 13F filings with the SEC.

Stay updated on Meritage Portfolio Management with notifications on news.